Was ist die Webseite?

https://www.mdpi.com/journal/vaccines

Vaccines MDPI, Basel (2025)

10/02/2025

💡"Sustained Liver HBsAg Loss and Clonal T- and B-Cell Expansion upon Therapeutic DNA Vaccination Require Low HBsAg Levels" by Nádia Conceição-Neto et al.
Read the full text here:

Background: Suppression of HBV DNA, inhibition of HBV surface (HBsAg) production and therapeutic vaccination to reverse HBV-specific T-cell exhaustion in chronic HBV patients are likely required to achieve a functional cure. In the AAV-HBV mouse model, therapeutic vaccination can be effective in cle...

10/02/2025

🌟 New Special Issue Launched!

📙 The Development of mRNA Vaccines
🎓 Guest editors: Dr. Minghui Yang, Dr. Yuming Li and Dr. Bo Hu.

This Special Issue aims to explore the latest advancements in mRNA vaccine research, encompassing a wide range of applications, from infectious disease prevention to tumor immunity. Topics of interest include innovative mRNA delivery systems that enhance stability and efficiency, novel vaccine designs targeting emerging pathogens and cancer antigens, and the development of next-generation adjuvants to optimize immune responses. Additionally, we welcome studies addressing manufacturing scalability, regulatory challenges, and strategies to broaden mRNA vaccine accessibility.

🔓 Submissions Deadline: 31 December 2025
For more information: https://brnw.ch/21wQAia

hashtag hashtag hashtag hashtag

Vaccines, an international, peer-reviewed Open Access journal.

10/02/2025

🌟 New Special Issue Launched!

📙 The Development of mRNA Vaccines

🎓 Guest editors: Dr. Minghui Yang, Dr. Yuming Li and Dr. Bo Hu.
This Special Issue aims to explore the latest advancements in mRNA vaccine research, encompassing a wide range of applications, from infectious disease prevention to tumor immunity. Topics of interest include innovative mRNA delivery systems that enhance stability and efficiency, novel vaccine designs targeting emerging pathogens and cancer antigens, and the development of next-generation adjuvants to optimize immune responses. Additionally, we welcome studies addressing manufacturing scalability, regulatory challenges, and strategies to broaden mRNA vaccine accessibility.

🔓 Submissions Deadline: 31 December 2025

For more information: https://brnw.ch/21wQAhv

Vaccines, an international, peer-reviewed Open Access journal.

10/02/2025

🌟 We are pleased to announce the upcoming special issue titled "The Immunotherapy Against Swine Disease," leading by Prof. Dr. Changlong Liu, Prof. Dr. Fei Gao, and Prof. Dr. Yanhua Li. 📚✍️

The special issue aims to explore recent advancements in immunotherapeutic strategies targeting viral and bacterial diseases that significantly affect both the swine industry and overall animal health. Emphasizing the importance of innovative approaches, we invite studies focused on vaccine development, monoclonal antibodies, and host immune modulation as essential components in enhancing swine health outcomes.

Manuscript submissions are welcomed until June 30, 2026. 🗓️
For further details, kindly visit our website: https://brnw.ch/21wQAh1

Vaccines, an international, peer-reviewed Open Access journal.

07/02/2025

🌟 Exciting Announcement! 🌟

We are thrilled to announce the launch of the special issue "Hepatitis Vaccines: Safety, Efficacy, and Global Impact.", leading by Dr. Muhammad Atif Zahoor.

In this Special Issue, we aim to address key questions related to viral hepatitis, including its prevention through vaccination, the safety and efficacy of current vaccines, and the broader global impact of these interventions. We invite the submission of original research and review articles that explore any aspect of viral hepatitis, the role of vaccines, and the innovations and challenges that will shape the future of hepatitis prevention worldwide.

Deadline for manuscript submissions: 30 September 2025
More details here: https://brnw.ch/21wQx4J

Vaccines, an international, peer-reviewed Open Access journal.

07/02/2025

🌟 New Special Issue Launched!

📙 Strategies and Innovations to Recover Post-Pandemic Losses in Routine Immunization Coverage
🎓 Guest editor: Dr. Noha H. Farag

Research areas may include (but are not limited to) the following:
- Innovative approaches to catch-up vaccination;
- Community engagement and communication strategies to increase vaccine demand and uptake;
- Policy and funding mechanisms to support immunization recovery;
- Technological innovations in vaccine delivery and monitoring.

🔓 Submissions Deadline: 5 August 2025
For more information: https://brnw.ch/21wQx3b

Vaccines, an international, peer-reviewed Open Access journal.

23/01/2025

🌟 New Special Issue Launched!
📙 Measles Outbreak: Causes and Vaccination Strategies to Overcome
🎓 Guest editors: Dr. Cristiana Ferrari and Dr. Nicolas Vignier

This Special Issue is hoping to attract original research articles and reviews that offer both global and region-specific perspectives, alongside evidence-based research and findings relevant to policy. The objective is to create a comprehensive collection of best practices in this field, supporting the development of resilient public health systems.

🔓 Submissions Deadline: 20 July 2025

For more information: https://brnw.ch/21wQbuP

Vaccines, an international, peer-reviewed Open Access journal.

23/01/2025

🌟 New Special Issue Launched! 🌟

"Factors Affecting and Strategies Enhancing the Willingness to Receive and Uptake of Seasonal Influenza Vaccination" guest edited by Dr. Paul Shing-fong Chan, The Education University of Hong Kong, China.

We invite you to contribute original research reports and review articles that explore the following areas:
(1) the levels and determinants of willingness to receive SIV;
(2) strategies to enhance willingness and uptake;
(3) facilitators and barriers to implementing SIV programs;
(4) the evaluation of SIV programs or interventions.

🗓️ Submissions Deadline: 30 November 2025

For more information and to submit your paper, visit: https://brnw.ch/21wQbuC 🌐

Vaccines, an international, peer-reviewed Open Access journal.

23/01/2025

🌟 Upcoming Partner Conferences!

Join us for the 22nd Lancefield International Symposium on Streptococci and Streptococcal Diseases (LISSSD 2025) from 1 to 5 June 2025 in Brisbane, Australia. 🇦🇺

🔗 More Info: https://brnw.ch/21wQbul

Conference Chairs: Assoc Prof. Manisha Pandey and Prof. Michael F Good AO, Griffith University, Australia 🎓

The meeting offers a cutting-edge scientific program covering the latest advances in clinical aspects, pathogenesis, novel diagnostics, therapeutics, and vaccine developments related to acute streptococcal infections as well as post-streptococcal sequelae.

Important Dates:

- 📝 Abstract submission deadline: 31 January 2025. To submit your abstract, please click here: https://brnw.ch/21wQbuo
- 🎟️ Early bird registration deadline: 28 March 2025. To register for the event, please click here: https://brnw.ch/21wQbum

Travel Grant:
- 💵Up to USD 1,500 towards travel (flights, transfers), accommodation, and incidentals.
- 🌏Eligibility for reduced low- and lower-middle-income country (LMIC) conference registration rates.
For more information about the travel grant, please click on the link here: https://brnw.ch/21wQbun

Vaccines, an international, peer-reviewed Open Access journal.

22/01/2025

🌟 New Special Issue Launched!
📙 Epidemiology of Diseases Preventable by Vaccination
🎓 Guest editors: Dr. Caterina Elisabetta Rizzo, Dr. Cristina Genovese and Dr. Roberto Venuto

This Special Issue aims to address key aspects of the epidemiology of vaccine-preventable diseases, enhance our understanding of their dynamics, and support the development of more effective and sustainable immunization programs worldwide. We welcome original research articles and reviews for consideration in this Special Issue.

🔓 Submissions Deadline: 31 December 2025

For more information: https://brnw.ch/21wQagC

Vaccines, an international, peer-reviewed Open Access journal.

21/01/2025

We are pleased to announce the winners of the Vaccines 2025 Travel Award 🎉. The award has been granted to Jesse Mulder, a Ph.D. student at Monash University, Melbourne, Australia 🇦🇺, and Hakam Alaqabani, a Ph.D. student at the University of Strathclyde, Glasgow, UK 🇬🇧.

Each winner will receive an honorarium of CHF 500 and an electronic certificate 📜.

With so many high-quality applicants, the evaluation process and final decision were challenging. We would like to thank all the applicants for submitting their diverse and fascinating range of research topics. On behalf of the assessment committee, we congratulate the winners on their accomplishments.

Vaccines, an international, peer-reviewed Open Access journal.

21/01/2025

👏We are pleased to announce a new special issue focused on "Vaccines for the Vulnerable Population" , led by Dr. My Kieu Ha from the Vaccine and Infectious Disease Institute at the University of Antwerp.

We are particularly interested in knowledge on the following themes:

1. The pathogen- or drug-induced mechanisms that may impact vaccine responsiveness;
2. Data on the immunogenicity and safety of standard and new vaccines;
3. Identifying biomarkers that could lead to more effective vaccination strategies.

We encourage you to submit your papers or abstracts by the deadline of December 31, 2025 📅.
Read more here: https://brnw.ch/21wQ8oo

Vaccines, an international, peer-reviewed Open Access journal.

21/01/2025

We are pleased to announce the publication of the first paper in our special issue, "Virus Pandemics and Vaccinations." https://brnw.ch/21wQ8o4 🎉

The study "The Effectiveness of COVID-19 Vaccines During the Pre-Omicron and Omicron Periods: A Retrospective Test-Negative Case–Control Study" by Romeo Brambilla et al., confirms that the COVID-19 vaccines 💉 protect adult patients from hospitalizations, including the subgroup ≥80 years, also during the period of the Omicron variant’s predominance.

Read the full text: https://brnw.ch/21wQ8o5

We invite you to submit your own research paper for consideration! ✍️📄

; ; ; ; ;

Background: The aim of this study was to estimate the effectiveness of original and bivalent COVID-19 vaccines in reducing COVID-19-associated hospitalizations among the adult population of Turin, Italy. Methods: We conducted a retrospective, test-negative, case–control study of 5768 adults aged ...

21/01/2025

🌟 Boost Your Immunity: Insights from ASU's COVID-19 Study 🌟

A study from Arizona State University Biodesign Institute reveals how COVID-19 boosters significantly extend the longevity of immune responses. Conducted in early 2023, this research highlights the importance of vaccination in maintaining high levels of anti-receptor binding domain (RBD) and neutralizing antibodies. With a 96.2% prevalence of anti-RBD antibodies among participants, the study underscores the effectiveness of multiple vaccine doses in enhancing immunity.

Key findings:
Booster vaccine doses = stronger and longer-lasting antibodies. 💉
Anti-RBD antibodies correlate strongly with neutralizing antibodies, crucial for fighting infections.
Boosters slow antibody decline, with higher doses showing improved immune durability.

This study emphasizes the importance of ongoing public health measures, vaccination access, and booster campaigns to combat new COVID-19 variants and maintain population immunity. With ASU's diverse community as the backdrop, this research provides valuable insights for global health strategies.

🔬 Read more about how vaccines are helping us build a safer, healthier future! https://brnw.ch/21wQ8nw

Background/Objectives: Since the World Health Organization declared COVID-19 a pandemic in March 2020, the virus has caused multiple waves of infection globally. Arizona State University (ASU), the largest four-year university in the United States, offers a uniquely diverse setting for assessing imm...

15/01/2025

📢 We are thrilled to announce the launch of the 2nd edition of our special issue, "Acceptance and Hesitancy in Vaccine Uptake: 2nd Edition"! 🎉 Following the success of our first edition, which featured 20 insightful papers and garnered over 27,191 views, we're eager to continue this important topic.

Special Issue Guest Editor: Dr. Sherri Sheinfeld Gorin
Deadline for manuscript submissions: 31 October 2025

Submissions are now open! 💻📝 Explore the details here: https://brnw.ch/21wQ0W7)

Vaccines, an international, peer-reviewed Open Access journal.

14/01/2025

🎉 We are pleased to announce the successful conclusion of our special issue on "Recent Research on Human Papillomavirus (HPV) Infection and Vaccination"! With 10 insightful papers published and over 20,000 views, your engagement has been invaluable. 🙌✨

👥 Guest Editors: Dr. Li Shi and Yufeng Yao, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, China.

📚 Read all papers here: https://brnw.ch/21wPYUM

🔔 Stay tuned for our upcoming second edition, where we will continue to explore this vital topic! 🌍💡

Vaccines, an international, peer-reviewed Open Access journal.

10/01/2025

💡 "Analyzing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate," by Jesús Hermosilla et al.

This study investigates the in-use stability of clinical samples from Comirnaty™ and Spikevax™, comparing their results. 📊 Although both vaccines utilize the same mRNA-LNP technology, the findings reveal distinct differences in their particle size profiles and their responses to various handling and stress conditions.

🔗 Access the full text here: 👇https://brnw.ch/21wPUb4

COVID-19 vaccines; Comirnaty™; Spikevax™; DLS; in-use stability testing; TEM

Comirnaty™ and Spikevax™ were the first vaccines approved for human use based on modified non-replicating mRNA lipophilic nanoparticle (mRNA-LNP) technology, with great success in the treatment of COVID-19. They have been used massively worldwide. One of the major inconveniences of these vaccine...

10/01/2025

🌟 New Special Issue Launched!
📙 Vaccines for the Vulnerable Population
🎓 Guest editor: Dr. My Kieu Ha

This Special Issue seeks to collect contemporary information on vaccination for vulnerable populations. We invite contributions from immunology and vaccinology experts to submit their original research, reviews, perspectives, and clinical trial reports. We are particularly interested in knowledge on the following themes:

1. 🦠 The pathogen- or drug-induced mechanisms that may impact vaccine responsiveness;
2. 💉 Data on the immunogenicity and safety of standard and new vaccines;
3. 🔍 Identifying biomarkers that could lead to more effective vaccination strategies.

🔓 Submissions Deadline: 31 January 2026
For more information: 🌐

Vaccines, an international, peer-reviewed Open Access journal.

Vaccines MDPI

10/02/2025

10/02/2025

10/02/2025

10/02/2025

07/02/2025

07/02/2025

23/01/2025

23/01/2025

23/01/2025

22/01/2025

21/01/2025

21/01/2025

21/01/2025

21/01/2025

15/01/2025

14/01/2025

10/01/2025

10/01/2025

Adresse

Webseite

Benachrichtigungen

Service Kontaktieren

Verknüpfungen

Teilen

Kategorie